 |
|
Home | BMO Capital Markets Reiterates “Outperform” Rating for Sangamo Biosciences (SGMO) |
 |
BMO Capital Markets Reiterates “Outperform” Rating for Sangamo Biosciences (SGMO)
|
 |
- May 22, 2015
-
Sangamo Biosciences (NASDAQ:SGMO)‘s stock had its “outperform” rating restated by BMO Capital Markets in a research note issued on Tuesday. They currently have a $19.00 price target on the stock. BMO Capital Markets’ price objective would indicate a potential upside of 52.61% from the company’s current price. In other Sangamo Biosciences news, major shareholder Ra […]This article (BMO Capital Markets Reiterates “Outperform” Rating for Sangamo Biosciences (SGMO)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2015/05/21/bmo-capital-markets-reiterates-outperform-rating-for-sangamo-biosciences-sgmo/
|
 |
|
 |
|
 |
